Results 21 to 30 of about 108,387 (211)

Treatment Patterns and Clinical Outcomes of Chronic Urticaria: Two-year Follow-up Results from the Scandinavian AWARE Study

Acta Dermato-Venereologica, 2022
The AWARE (A World-wide Antihistamine-Refractory chronic urticaria patient Evaluation) study investigated outcomes in patients with chronic urticaria refractory to H1-antihistamine.
Simon F. Thomsen, Ellen C. Pritzier, Chris D. Anderson, Siri Juvik, Nicolas V. Baust, Rikke Dodge, Anna-Karin Dahlborn, Christian Vestergaard   +7 more
doaj   +1 more source

Oral H1 antihistamines as monotherapy for eczema [PDF]

Cochrane Database of Systematic Reviews, 2013
Eczema is a common skin disease in many countries, and although the majority of cases of eczema occur before the age of five years and often resolve during childhood or adolescence, it can also persist into adulthood. Itch is the most important aspect of eczema, often impacting significantly on the quality of life of an affected individual.To assess ...
Apfelbacher, C.J., Zuuren, E.J. van, Fedorowicz, Z., Jupiter, A., Matterne, U., Weisshaar, E.   +5 more
openaire   +3 more sources

Efficacy and safety of total glucosides of paeony as an add-on treatment in adolescents and adults with chronic urticaria: A systematic review and meta-analysis

Frontiers in Pharmacology, 2022
Background: Total glycosides of paeony (TGP), an active compound extracted from the dried roots of Paenoia lactiflora Pall., has been widely used to treat chronic urticaria (CU) in China. This study aims to systematically evaluate the efficacy and safety
Ming Li, Yan Li, Lujing Xiang, Linfeng Li   +3 more
doaj   +1 more source

Antihistamines in Pregnancy [PDF]

Journal of Pediatrics Review, 2023
Allergic disorders are increasing prevalence from decades. Often of allergic diseases such as chronic urticaria in some aspects of quality of life of patients affected. Outdoor and indoor allergens can cause   aggravation of symptoms in allergic patients.
Javad Ghaffari
doaj  

Combination of Leukotoriene Receptor Antagonist With Antihistamine Has an Additive Suppressive Effect on the Up-regulation of H1-Receptor mRNA in the Nasal Mucosa of Toluene 2,4-Diisocyanate-Sensitized Rat

Journal of Pharmacological Sciences, 2013
.: An attempt was made to clarify the additive suppressive effects of pranlukast, a cysteinyl leukotriene–receptor (LTR) antagonist, in combination with chlorpheniramine, an antihistamine, on the up-regulation of histamine H1–receptor (H1R) mRNA in ...
Wakana Kuroda, Yoshiaki Kitamura, Hiroyuki Mizuguchi, Yuko Miyamoto, Bukasa Kalubi, Hiroyuki Fukui, Noriaki Takeda   +6 more
doaj   +1 more source

H1-antihistamines for chronic spontaneous urticaria [PDF]

Cochrane Database of Systematic Reviews, 2014
Background Chronic spontaneous urticaria (CSU) is characterised by the development of crops of red, itchy, raised weals or hives with no identifiable external cause.Objectives To assess the effects of H1-antihistamines for CSU.Search methods We searched the following databases up to June 2014: Cochrane Skin Group Specialised Register, CENTRAL (2014 ...
Maulina, Sharma, Cathy, Bennett, Stuart N, Cohen, Ben, Carter   +3 more
openaire   +2 more sources

Benefits of ebastine from the position of clinical pharmacology

Лечащий Врач, 2023
The article reviews data on pharmacokinetics, pharmacodynamics, efficacy and safety of ebastine, presents reviews of the most significant clinical trials in the treatment of allergic diseases (allergic rhinitis, urticaria) and comparative studies with ...
D. Yu. Ivkin, A. Yu. Grishina, A. G. Petrova, E. V. Moskaleva, N. O. Selizarova   +4 more
doaj   +1 more source

Optimization of treatment of children with respiratory infections combined with allergic rhinitis

Zdorovʹe Rebenka, 2017
Optimization of treatment both acute viral respiratory infections and allergic diseases is a very actual task in current pediatrics. Allergic respiratory pathology is associated with viral infections.
S.P. Kryvopustov
doaj   +1 more source

Understanding the ionization pattern of bilastine, histamine H1 receptor antagonist

Bilastine is a second-generation oral H1 antihistamine approved for the use in symptomatic treatment of allergic rhinoconjunctivitis and urticaria with the advantage of its favourable tolerability profile and the long duration of action [1]. ..
Popović-Nikolić, Marija, Nikolić, Katarina, Popović, Gordana, Oljačić, Slavica   +3 more
core   +4 more sources

The potential impact of H1 antihistamines on clinical outcomes in NSCLC patients undergoing EGFR‐TKIs treatment

British Journal of Clinical Pharmacology, EarlyView.
Background Epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR‐TKIs) have substantially improved outcomes in non‐small cell lung cancer (NSCLC); however, the development of treatment resistance remains a major clinical challenge. This study examines the association between concomitant prescriptions of H1‐antihistamines (H1AHs) and ...
Van Thuan Nguyen, Ngoc Hoang Le, Nhu Quynh Phan, Toan Trung Duong, Le Thi Anh Thu, Hsuan‐Chia Yang, Chih‐Wei Huang, Min‐Huei Hsu, Jason C. Hsu, Chien‐Tien Su, Phung‐Anh Nguyen   +10 more
wiley   +1 more source